Issue 2, January 13, 2015

Each Tuesday, to enhance awareness of emerging scientific knowledge, selected science clips will be posted here for the public health community. The focus is applied public health research and prevention science that has the capacity to improve health now.

1. Top Ten Articles of the Week
   Selected weekly by a senior CDC scientist from the standard sections listed below.
   • Chronic Diseases and Conditions
     • Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors
       Halldin CN, Doney BC, Hnizdo E.
       Chron Respir Dis. 2014 Dec 24.
       
     • Considering trends in sodium, trans fat, and saturated fat as key metrics of cardiometobolic risk reduction
       Posner SF, Bowman BA, Collins JL.
       Prev Chronic Dis. 2014 ;11:E230.
       
   • Communicable Diseases
     • Contribution of influenza to acute exacerbations of chronic obstructive pulmonary disease in Kashmir, India, 2010-2012
       Koul PA, Khan UH, Asad R, Yousuf R, Broor S, Lal RB, Dawood FS.
       Influenza Other Respir Viruses. 2015 Jan;9(1):40-2.
       
     • Targeting the use of pooled HIV RNA screening to reduce cost in health department STD clinics: New York City, 2009-2011
       Borges CM, Pathela P, Pirillo R, Blank S.
       Public Health Rep. 2015 Jan;130(1):81-6.
       
   • Epidemiology and Surveillance
     • Challenges to implementing communicable disease surveillance in New York City evacuation shelters after Hurricane Sandy, November 2012
       Ridpath AD, Bregman B, Jones L, Reddy V, Waechter H, Balter S.
       Public Health Rep. 2015 Jan;130(1):48-53.
       
   • Food Safety
     • Increased outbreaks associated with nonpasteurized milk, United States, 2007-2012
       Mungai EA, Behravesh CB, Gould LH.
       Emerg Infect Dis. 2015 ;21(1):119-22.
       
   • Healthcare Economics
     • A systematic review on cost effectiveness of HIV prevention interventions in the United States
       Huang YA, Lasry A, Hutchinson AB, Sansom SL.
       Appl Health Econ Health Policy. 2014 Dec 25.
       
   • Laboratory Sciences
     • Evidence from 617 laboratories in 47 countries for SLMTA-driven improvement in quality management systems
       Yao K, Luman ET.
       Afr J Lab Med. 2014 ;3(2):1-11.
       
   • Zoonoses
     • Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009
       Conger NG, Paolino KM, Osborn EC, Rusnak JM, Gunther S, Pool J, Rollin PE, Allan PF, Schmidt-Chanasit J, Rieger T, Kortepeter MG.
       Emerg Infect Dis. 2015 ;21(1):23-31.
       
     • Epidemiology of human plague in the United States, 1900-2012
       Kugeler KJ, Staples JE, Hinckley AF, Gage KL, Mead PS.
       Emerg Infect Dis. 2015 Jan;21(1):16-22.
       
   
   
2. CDC Authored Publications
   The names of CDC authors are indicated in bold text.
   Articles published in the past 6-8 weeks authored by CDC or ATSDR staff.
   • Communicable Diseases
     1. Adapting and implementing a community program to improve retention in care among patients with HIV in Southern Haiti: "Group of 6"
        Naslund JA, Dionne-Odom J, Junior Destine C, Jogerst KM, Renold Senecharles R, Jean Louis M, Desir J, Neptune Ledan Y, Beausejour JR, Charles R, Werbel A, Talbot EA, Joseph P, Pape JW, Wright PF.
        AIDS Res Treat. 2014 ;2014:137545.
        
     2. Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with >95% vaccine coverage, Israel 2013
        Shulman LM, Martin J, Sofer D, Burns CC, Manor Y, Hindiyeh M, Gavrilin E, Wilton T, Moran-Gilad J, Gamzo R, Mendelson E, Grotto I.
        Clin Infect Dis. 2014 Dec 30.
        
     3. Improved survival with co-trimoxazole prophylaxis among people living with HIV/AIDS who initiated antiretroviral treatment in Henan Province, China
        Zhu Q, Wang L, Lin W, Bulterys M, Yang W, Sun D, Cui Z, Kaplan J, Kleinman N, Wei X, Chung J, Wang Z.
        Curr HIV Res. 2014 ;12(5):359-65.
        
     4. Enhancing the benefits of antiretroviral therapy in Vietnam: towards ending AIDS
        Kato M, Long NH, Duong BD, Nhan do T, Nguyen TT, Hai NH, Giang le M, Hoa do M, Van NT, Suthar AB, Fontaine C, Nadol P, Lo YR, McConnell MS.
        Curr HIV/AIDS Rep. 2014 Dec;11(4):487-95.
        
     5. Community-acquired invasive GAS disease among Native Americans, Arizona, USA, winter 2013
        Harris AM, Yazzie D, Antone-Nez R, Dine-Chacon G, Kinlacheeny JB, Foley D, Yasmin S, Adams L, Livar E, Terranella A, Yeager L, Komatsu K, Van Beneden C, Langley G.
        Emerg Infect Dis. 2015 ;21(1):177-9.
        
     6. Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14
        Okomo-Adhiambo M, Fry AM, Su S, Nguyen HT, Elal AA, Negron E, Hand J, Garten RJ, Barnes J, Xiyan X, Villanueva JM, Gubareva LV.
        Emerg Infect Dis. 2015 ;21(1):136-41.
        
     7. Antiviral treatment among pregnant women with chronic hepatitis B
        Fan L, Owusu-Edusei K, Schillie SF, Murphy TV.
        Infect Dis Obstet Gynecol. 2014 ;2014:546165.
        
     8. Clinical characteristics and genotypes of rotavirus in adults
        Anderson EJ, Shippee DB, Tate JE, Larkin B, Bregger MD, Katz BZ, Noskin GA, Sederdahl BK, Shane AL, Parashar UD, Yogev R.
        J Infect. 2014 Dec 4.
        
     9. Treatment outcomes of patients with tuberculosis in New York City
        Bhavnani D, Lancki N, Winter I, Macaraig M.
        J Public Health Manag Pract. 2014 Dec 30.
        
     10. Notes from the field: aseptic meningitis outbreak associated with echovirus 30 among high school football players - Los Angeles County, California, 2014
         Croker C, Civen R, Keough K, Ngo V, Marutani A, Schwartz B.
         MMWR Morb Mortal Wkly Rep. 2015 Jan 2;63(51):1228.
         
     11. Perceptions of the risk for Ebola and health facility use among health workers and pregnant and lactating women - Kenema District, Sierra Leone, September 2014
         Dynes MM, Miller L, Sam T, Vandi MA, Tomczyk B.
         MMWR Morb Mortal Wkly Rep. 2015 Jan 2;63(51):1226-7.
         
     12. Human papillomavirus prevalence in invasive laryngeal cancer in the United States
         Hernandez BY, Goodman MT, Lynch CF, Cozen W, Unger ER, Steinau M, Thompson T, Saber MS, Altekruse SF, Lyu C, Saraiya M.
         PLoS One. 2014 ;9(12):e115931.
         
     13. Serotype 10A in case patients with invasive pneumococcal disease: a pilot study of PCR-based serotyping in New Jersey
         Pitts SI, Apostolou A, DasGupta S, Delgado N, Kirn TJ, Montana B, Tan C, McHugh LA.
         Public Health Rep. 2015 Jan;130(1):54-9.
         
   • Community Health Services
     14. Time spent with patients by physicians, nurse practitioners, and physician assistants in community health centers, 2006-2010
         Morgan P, Everett CM, Hing E.
         Healthc (Amst). 2014 ;2(4):232-237.
         
   • Disaster Control and Emergency Services
     15. Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterprise
         Coleman CN, Sullivan JM, Bader JL, Murrain-Hill P, Koerner JF, Garrett AL, Weinstock DM, Case C, Hrdina C, Adams SA, Whitcomb RC, Graeden E, Shankman R, Lant T, Maidment BW, Hatchett RC.
         Health Phys. 2015 Feb;108(2):149-60.
         
   • Drug Safety
     16. Endophthalmitis outbreak associated with repackaged bevacizumab
         Edison LS, Dishman HO, Tobin-D'Angelo MJ, Allen CR, Guh AY, Drenzek CL.
         Emerg Infect Dis. 2015 ;21(1):171-3.
         
   • Environmental Health
     17. Temporal variability of polybrominated diphenyl ether (PBDE) serum concentrations over one year
         Makey CM, McClean MD, Sjodin A, Weinberg J, Carignan CC, Webster TF.
         Environ Sci Technol. 2014 Dec 16;48(24):14642-9.
         
   • Food Safety
     18. Occurrence and molecular characterization of Cryptosporidium spp. and Enterocytozoon bieneusi in dairy cattle, beef cattle and water buffaloes in China
         Ma J, Li P, Zhao X, Xu H, Wu W, Wang Y, Guo Y, Wang L, Feng Y, Xiao L.
         Vet Parasitol. 2014 Oct 25.
         
   • Genetics and Genomics
     19. Phylodynamic analysis of clinical and environmental Vibrio cholerae isolates from Haiti reveals diversification driven by positive selection
         Azarian T, Ali A, Johnson JA, Mohr D, Prosperi M, Veras NM, Jubair M, Strickland SL, Rashid MH, Alam MT, Weppelmann TA, Katz LS, Tarr CL, Colwell RR, Morris JG, Salemi M.
         MBio. 2014 ;5(6).
         
   • Health Behavior and Risk
     20. Health risk behaviors by length of time in the United States among high school students in five sites
         Jones SE, Pezzi C, Rodriguez-Lainz A, Whittle L.
         J Immigr Minor Health. 2014 Dec 24.
         
   • Immunity and Immunization
     21. Circulating vaccine-derived polioviruses in the extreme north region of Cameroon
         Endegue-Zanga MC, Sadeuh-Mba SA, Iber J, Burns C, Nimpa-Mengouo M, Demanou M, Vernet G, Etoa FX, Njouom R.
         J Clin Virol. 2015 Jan;62:80-3.
         
     22. Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012
         Rabe IB, Miller ER, Fischer M, Hills SL.
         Vaccine. 2014 Dec 9.
         
   • Laboratory Sciences
     23. Driving hospital transformation with SLMTA in a regional hospital in Cameroon
         Eno LT, Asong T, Ngale E, Mangwa B, Ndasi J, Mouladje M, Lekunze R, Mbome V, Njukeng P, Shang J.
         Afr J Lab Med. 2014 ;3(2).
         
     24. Attaining ISO 15189 accreditation through SLMTA: a journey by Kenya's National HIV Reference Laboratory
         Gachuki T, Sewe R, Mwangi J, Turgeon D, Garcia M, Luman ET, Umuro M.
         Afr J Lab Med. 2014 ;3(2).
         
     25. The impact of SLMTA in improving laboratory quality systems in the Caribbean region
         Guevara G, Gordon F, Irving Y, Whyms I, Parris K, Beckles S, Maruta T, Ndlovu N, Albalak R, Alemnji G.
         Afr J Lab Med. 2014 ;3(2).
         
     26. Progressing beyond SLMTA: are internal audits and corrective action the key drivers of quality improvement?
         Maina RN, Mengo DM, Mohamud AD, Ochieng SM, Milgo SK, Sexton CJ, Moyo S, Luman ET.
         Afr J Lab Med. 2014 ;3(2).
         
     27. Using standard and institutional mentorship models to implement SLMTA in Kenya
         Makokha EP, Mwalili S, Basiye FL, Zeh C, Emonyi WI, Langat R, Luman ET, Mwangi J.
         Afr J Lab Med. 2014 ;3(2).
         
     28. Working toward a sustainable laboratory quality improvement programme through country ownership: Mozambique's SLMTA story
         Masamha J, Skaggs B, Pinto I, Mandlaze AP, Simbine C, Chongo P, de Sousa L, Kidane S, Yao K, Luman ET, Samogudo E.
         Afr J Lab Med. 2014 ;3(2).
         
     29. Accelerating the spread of laboratory quality improvement efforts in Botswana
         Mokobela KO, Moatshe MT, Modukanele M.
         Afr J Lab Med. 2014 ;3(2).
         
     30. Decentralised facility-based training as an alternative model for SLMTA implementation: the Cameroon experience
         Ndasi J, Dimite L, Mbome V, Awasom C, Ngale E, Akuro S, Leonard E, Bolu O, Asong T, Njukeng P, Shang J.
         Afr J Lab Med. 2014 ;3(2).
         
     31. SLIPTA e-tool improves laboratory audit process in Vietnam and Cambodia
         Nguyen TT, McKinney B, Pierson A, Luong KN, Hoang QT, Meharwal S, Carvalho HM, Nguyen CQ, Nguyen KT, Bond KB.
         Afr J Lab Med. 2014 ;3(2):1-5.
         
     32. Building local human resources to implement SLMTA with limited donor funding: the Ghana experience
         Nkrumah B, van der Puije B, Bekoe V, Adukpo R, Kotey NA, Yao K, Fonjungo PN, Luman ET, Duh S, Njukeng PA, Addo NA, Khan FN, Woodfill CJ.
         Afr J Lab Med. 2014 ;3(2).
         
     33. Maximising mentorship: variations in laboratory mentorship models implemented in Zimbabwe
         Nzombe P, Luman ET, Shumba E, Mangwanya D, Simbi R, Kilmarx PH, Zimuto SN.
         Afr J Lab Med. 2014 ;3(2).
         
     34. Weighing the costs: implementing the SLMTA programme in Zimbabwe using internal versus external facilitators
         Shumba E, Nzombe P, Mbinda A, Simbi R, Mangwanya D, Kilmarx PH, Luman ET, Zimuto SN.
         Afr J Lab Med. 2014 ;3(2):1-6.
         
     35. The SLMTA programme: transforming the laboratory landscape in developing countries
         Yao K, Maruta T, Luman ET, Nkengasong JN.
         Afr J Lab Med. 2014 ;3(2).
         
     36. Relative insignificance of virus inactivation during aluminum electrocoagulation of saline waters
         Tanneru CT, Narayanan J, Hill VR, Chellam S.
         Environ Sci Technol. 2014 Dec 16;48(24):14590-8.
         
     37. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia
         Roca-Feltrer A, Khim N, Kim S, Chy S, Canier L, Kerleguer A, Tor P, Chuor CM, Kheng S, Siv S, Kachur PS, Taylor WR, Hwang J, Menard D.
         PLoS One. 2014 ;9(12):e116143.
         
   • Occupational Safety and Health
     38. Application of an informatics-based decision-making framework and process to the assessment of radiation safety in nanotechnology
         Hoover MD, Myers DS, Cash LJ, Guilmette RA, Kreyling WG, Oberdorster G, Smith R, Cassata JR, Boecker BB, Grissom MP.
         Health Phys. 2015 Feb;108(2):179-94.
         
     39. 2014 updates to the NIOSH hazardous drug list
         Connor TH, MacKenzie BA.
         Pharm Purch Prod. 2015 Nov;11(11):90,92,96.
         
     40. Modifying welding process parameters can reduce the neurotoxic potential of manganese-containing welding fumes
         Sriram K, Lin GX, Jefferson AM, Stone S, Afshari A, Keane MJ, McKinney W, Jackson M, Chen BT, Schwegler-Berry D, Cumpston A, Cumpston JL, Roberts JR, Frazer DG, Antonini JM.
         Toxicology. 2014 Dec 27.
         
   • Parasitic Diseases
     41. Plasmodium vivax trophozoite-stage proteomes
         Anderson DC, Lapp SA, Akinyi S, Meyer EV, Barnwell JW, Korir-Morrison C, Galinski MR.
         J Proteomics. 2014 Dec 27.
         
   • Social and Behavioral Sciences
     42. Relationship between social cognitive theory constructs and self-reported condom use: assessment of behaviour in a subgroup of the Safe in the City trial
         Snead MC, O'Leary AM, Mandel MG, Kourtis AP, Wiener J, Jamieson DJ, Warner L, Malotte CK, Klausner JD, O'Donnell L, Rietmeijer CA, Margolis AD.
         BMJ Open. 2014 ;4(12):e006093.
         
     43. Parenthood and leaving home in young adulthood
         Goldscheider FK, Hofferth SL, Curtin SC.
         Popul Res Policy Rev. 2014 Dec;33(6):771-796.
         
   • Substance Use and Abuse
     44. Tobacco cessation among users of telephone and web-based interventions - four states, 2011-2012
         Puckett M, Neri A, Thompson T, Underwood JM, Momin B, Kahende J, Zhang L, Stewart SL.
         MMWR Morb Mortal Wkly Rep. 2015 Jan 2;63(51):1217-21.
         
   • Vital Statistics
     45. Validation of selected items on the 2003 U.S. Standard Certificate of Live Birth: New York City and Vermont
         Dietz P, Bombard J, Mulready-Ward C, Gauthier J, Sackoff J, Brozicevic P, Gambatese M, Nyland-Funke M, England L, Harrison L, Farr S.
         Public Health Rep. 2015 Jan;130(1):60-70.
         
   • Zoonoses
     46. Streptococcus equi subsp. zooepidemicus infections associated with guinea pigs
         Gruszynski K, Young A, Levine SJ, Garvin JP, Brown S, Turner L, Fritzinger A, Gertz RE, Murphy JM, Vogt M, Beall B.
         Emerg Infect Dis. 2015 ;21(1):156-8.
         
     47. Bartonella clarridgeiae bacteremia detected in an asymptomatic blood donor
         Vieira-Damiani G, Diniz PP, Pitassi LH, Sowy S, Scorpio DG, Lania BG, Drummond MR, Soares TC, Barjas-Castro Mde L, Breitschwerdt EB, Nicholson WL, Velho PE.
         J Clin Microbiol. 2015 Jan;53(1):352-6.
         
     48. Structural and functional analysis of surface proteins from an A(H3N8) influenza virus isolated from New England harbor seals
         Yang H, Nguyen HT, Carney PJ, Guo Z, Chang JC, Jones J, Davis CT, Villanueva JM, Gubareva LV, Stevens J.
         J Virol. 2014 Dec 24.
         
     49. Clinical presentation, convalescence, and relapse of Rocky Mountain spotted fever in dogs experimentally infected via tick bite
         Levin ML, Killmaster LF, Zemtsova GE, Ritter JM, Langham G.
         PLoS One. 2014 ;9(12):e115105.
         
   
   

Back to Top

CDC Science Clips Production Staff

• John Iskander, MD MPH, Editor
• Jane Gidudu, MD, MPH, Acting Editor
• Gail Bang, MLIS, Librarian
• William (Bill) Thomas, MLIS, Librarian
• Victoria Burchfield, MLIS, Librarian
• Kathleen Connick, MSLS, Librarian
• Jarvis Sims, MIT, MLIS, Librarian
• Mathieu Mazarin, BA, Web Developer/Designer

____

DISCLAIMER: Articles listed in the CDC Science Clips are selected by the Stephen B. Thacker CDC Library to provide current awareness of the public health literature. An article's inclusion does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the Clips, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.